NovoSorb SynPath is a sterile, acellular, synthetic dermal matrix made from the proprietary NovoSorb technology
INTENDED USES: It is indicated for management of partial and full thickness wounds, chronic ulcers (pressure, venous, diabetic), surgical wounds, and traumatic wounds.
CLAIMED BENEFITS: The porous network of non-toxic, biodegradable synthetic polymers acts as a template to support the proliferation of vital cells involved in cellular repair. As the matrix integrates into the wound bed, it supports the creation of a neodermal structure. The fenestrated matrix allows excess exudate from the wound to pass through to a secondary absorbent dressing to prevent maceration. The matrix is covered by a sealing membrane that reduces water vapor loss, helps maintain a moist wound environment, and acts as a barrier to prevent external contamination of the wound. The membrane remains intact with the dermal matrix until the clinician determines when to remove it based on the wound progression, the need for surgical closure or grafting, or application of another dermal template.
OPTIONS: Per square centimeter
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care